-
公开(公告)号:EP2603216A1
公开(公告)日:2013-06-19
申请号:EP11816983.8
申请日:2011-08-10
发明人: CULLIS, Courtney, A. , GRANGER, Krista, E. , GUO, Jianping , HIROSE, Masaaki , LI, Gang , MIZUTANI, Miho , VOS, Tricia, J.
IPC分类号: A61K31/422
CPC分类号: A61K31/422 , C07D405/04 , C07D405/14 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/14 , C07D471/04
摘要: This invention provides compounds of formula IA or IB: wherein HY, R1, R2, and G1, are as described in the specification. The compounds are inhibitors of VPS34 and/or PI3K and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
-
公开(公告)号:EP2391619A1
公开(公告)日:2011-12-07
申请号:EP10703376.3
申请日:2010-01-28
发明人: BANNO, Hiroshi , HIROSE, Masaaki , KURASAWA, Osamu , LANGSTON, Steven, P. , MIZUTANI, Hirotake , SHI, Zhan , VISIERS, Irache , VOS, Tricia, J. , VYSKOCIL, Stepan
IPC分类号: C07D417/04 , C07D419/14 , C07D471/04 , C07D487/04 , C07D513/04 , A61K31/404 , A61P29/00
CPC分类号: C07D487/04 , C07D417/04 , C07D419/14 , C07D471/04 , C07D513/04
摘要: This invention provides compounds of formula (IA) or (IB): wherein R
1 , R
2 , G
1 and HY are as described in the specification. The compounds are inhibitors of PI3K and/or mTor and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.-
3.
公开(公告)号:EP3131881A1
公开(公告)日:2017-02-22
申请号:EP15779407.4
申请日:2015-04-17
发明人: GIGSTAD, Kenneth, M. , CARDIN, David, P. , HIRAYAMA, Takaharu , HIROSE, Masaaki , HU, Yongbo , KAKEI, Hiroyuki , LEE, Hong, Myung , MOTOYAJI, Takashi , NII, Noriyuki , SHI, Zhan , VYSKOCIL, Stepan , WATANABE, Hiroyuki
IPC分类号: C07D241/36 , C07D401/14 , C07D403/12
CPC分类号: C07D498/04 , A61K31/498 , A61K31/4985 , A61K31/501 , A61K31/506 , A61K31/5375 , A61K31/541 , A61K31/55 , A61K31/553 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/12 , C07D417/14 , C07D471/04 , C07D487/04 , C07D491/08 , C07D491/107 , C07D491/113
摘要: This invention provides compounds of formula I and subsets thereof: wherein T, J, R, R4, Rq, o, RA, and RB and subsets thereof are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, or T-cell mediated autoimmune disease.
摘要翻译: 本发明提供式I化合物及其子集:其中T,J,R,R 4,R q,o,RA和R B及其子集如说明书中所述。 这些化合物是NAMPT的抑制剂,因此可用于治疗癌症,炎性病症或T细胞介导的自身免疫性疾病。
-
公开(公告)号:EP2603214A1
公开(公告)日:2013-06-19
申请号:EP11817031.5
申请日:2011-08-11
发明人: FREEZE, Brian S. , HIROSE, Masaaki , HU, Yongbo , HU, Zhigen , LEE, Hong Myung , SELLS, Todd B. , SHI, Zhan , VYSKOCIL, Stepan , XU, Tianlin
IPC分类号: A61K31/33 , A61K31/425
CPC分类号: C07D277/56 , A61K31/4155 , A61K31/425 , A61K31/437 , A61K31/4375 , A61K31/4439 , A61K31/4725 , A61K31/495 , A61K31/496 , A61K31/497 , A61K31/501 , A61K31/506 , A61K45/06 , C07D277/64 , C07D293/06 , C07D333/38 , C07D333/54 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/14 , C07D471/04 , C07D491/107 , C07D495/04
摘要: This invention provides compounds of formula IA-a or IB-a and subsets thereof: wherein Z, HY, R1, R2, G1, W, n, and A and subsets thereof are as described in the specification. The compounds are inhibitors of PI3K and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
摘要翻译: 本发明提供了式IA-a或IB-a的化合物及其子集:其中Z,HY,R 1,R 2,G 1,W,n和A及其亚组如说明书中所述。 该化合物是PI3K的抑制剂,因此可用于治疗增殖性,炎症性或心血管疾病。
-
公开(公告)号:EP2627181A2
公开(公告)日:2013-08-21
申请号:EP11833402.8
申请日:2011-10-13
发明人: FREEZE, Brian, S. , HIROSE, Masaaki , LEE, Hong Myung , SELLS, Todd, B. , SHI, Zhan , TAKAOKA, Leo, R. , VYSKOCIL, Stepan , XU, Tianlin
IPC分类号: A01N43/78 , A61K31/425 , A01N43/16 , A61K31/35 , A61K31/365
CPC分类号: C07D519/00 , A61K9/2018 , C07D333/78 , C07D409/04 , C07D409/14 , C07D471/04 , C07D495/04 , C07D513/04
摘要: This invention provides compounds of formula I-A or I-B: wherein HY, G
1 G
2 , R
2 , R
12 , W
1 , W
2 , n, and Ring A are as described in the specification. The compounds are inhibitors of PI3K and/or mTor and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.摘要翻译: 本发明提供了式I-A或I-B的化合物:其中HY,G 1 G 2,R 2,R 12,W 1,W 2,n和环A如说明书中所述。 该化合物是PI3K和/或mTor的抑制剂,因此可用于治疗增殖性,炎症或心血管疾病。
-
-
-
-